These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 10493945

  • 1. MDM2 oncogene as a target for cancer therapy: An antisense approach.
    Wang H, Zeng X, Oliver P, Le LP, Chen J, Chen L, Zhou W, Agrawal S, Zhang R.
    Int J Oncol; 1999 Oct; 15(4):653-60. PubMed ID: 10493945
    [Abstract] [Full Text] [Related]

  • 2. Antisense anti-MDM2 oligonucleotides as a novel therapeutic approach to human breast cancer: in vitro and in vivo activities and mechanisms.
    Wang H, Nan L, Yu D, Agrawal S, Zhang R.
    Clin Cancer Res; 2001 Nov; 7(11):3613-24. PubMed ID: 11705884
    [Abstract] [Full Text] [Related]

  • 3. Anti-tumor efficacy of a novel antisense anti-MDM2 mixed-backbone oligonucleotide in human colon cancer models: p53-dependent and p53-independent mechanisms.
    Wang H, Nan L, Yu D, Lindsey JR, Agrawal S, Zhang R.
    Mol Med; 2002 Apr; 8(4):185-99. PubMed ID: 12149568
    [Abstract] [Full Text] [Related]

  • 4. Experimental therapy of human prostate cancer by inhibiting MDM2 expression with novel mixed-backbone antisense oligonucleotides: in vitro and in vivo activities and mechanisms.
    Wang H, Yu D, Agrawal S, Zhang R.
    Prostate; 2003 Feb 15; 54(3):194-205. PubMed ID: 12518324
    [Abstract] [Full Text] [Related]

  • 5. Radiosensitization by antisense anti-MDM2 mixed-backbone oligonucleotide in in vitro and in vivo human cancer models.
    Zhang Z, Wang H, Prasad G, Li M, Yu D, Bonner JA, Agrawal S, Zhang R.
    Clin Cancer Res; 2004 Feb 15; 10(4):1263-73. PubMed ID: 14977824
    [Abstract] [Full Text] [Related]

  • 6. Chemosensitization and radiosensitization of human cancer by antisense anti-MDM2 oligonucleotides: in vitro and in vivo activities and mechanisms.
    Wang H, Oliver P, Zhang Z, Agrawal S, Zhang R.
    Ann N Y Acad Sci; 2003 Dec 15; 1002():217-35. PubMed ID: 14751837
    [Abstract] [Full Text] [Related]

  • 7. Antisense anti-MDM2 oligonucleotides as a novel approach to the treatment of glioblastoma multiforme.
    Prasad G, Wang H, Agrawal S, Zhang R.
    Anticancer Res; 2002 Dec 15; 22(1A):107-16. PubMed ID: 12017271
    [Abstract] [Full Text] [Related]

  • 8. Antisense anti-MDM2 mixed-backbone oligonucleotides enhance therapeutic efficacy of topoisomerase I inhibitor irinotecan in nude mice bearing human cancer xenografts: In vivo activity and mechanisms.
    Wang H, Wang S, Nan L, Yu D, Agrawal S, Zhang R.
    Int J Oncol; 2002 Apr 15; 20(4):745-52. PubMed ID: 11894120
    [Abstract] [Full Text] [Related]

  • 9. MDM2 oncogene as a novel target for human cancer therapy.
    Zhang, Wang H.
    Curr Pharm Des; 2000 Mar 15; 6(4):393-416. PubMed ID: 10788589
    [Abstract] [Full Text] [Related]

  • 10. A novel MDM2 anti-sense oligonucleotide has anti-tumor activity and potentiates cytotoxic drugs acting by different mechanisms in human colon cancer.
    Tortora G, Caputo R, Damiano V, Bianco R, Chen J, Agrawal S, Bianco AR, Ciardiello F.
    Int J Cancer; 2000 Dec 01; 88(5):804-9. PubMed ID: 11072252
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Consequences of the inhibition of Hdm2 expression in human osteosarcoma cells using antisense oligonucleotides.
    Geiger T, Hüsken D, Weiler J, Natt F, Woods-Cook KA, Hall J, Fabbro D.
    Anticancer Drug Des; 2000 Dec 01; 15(6):423-30. PubMed ID: 11716435
    [Abstract] [Full Text] [Related]

  • 15. Effects of MDM2 inhibitors on vascular endothelial growth factor-mediated tumor angiogenesis in human breast cancer.
    Xiong J, Yang Q, Li J, Zhou S.
    Angiogenesis; 2014 Jan 01; 17(1):37-50. PubMed ID: 23907365
    [Abstract] [Full Text] [Related]

  • 16. The roles of E6-AP and MDM2 in p53 regulation in human papillomavirus-positive cervical cancer cells.
    Traidej M, Chen L, Yu D, Agrawal S, Chen J.
    Antisense Nucleic Acid Drug Dev; 2000 Feb 01; 10(1):17-27. PubMed ID: 10726657
    [Abstract] [Full Text] [Related]

  • 17. Antisense therapy targeting MDM2 oncogene in prostate cancer: Effects on proliferation, apoptosis, multiple gene expression, and chemotherapy.
    Zhang Z, Li M, Wang H, Agrawal S, Zhang R.
    Proc Natl Acad Sci U S A; 2003 Sep 30; 100(20):11636-41. PubMed ID: 13130078
    [Abstract] [Full Text] [Related]

  • 18. Novel antisense anti-MDM2 mixed-backbone oligonucleotides: proof of principle, in vitro and in vivo activities, and mechanisms.
    Zhang R, Wang H, Agrawal S.
    Curr Cancer Drug Targets; 2005 Feb 30; 5(1):43-9. PubMed ID: 15720188
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.